EverGlade Insights Blog
Overview In a major development for the biomedical research community, the National Institutes of Health (NIH) has officially acknowledged that its recent funding freeze was unlawful and has announced the resumption of grant distributions. This...
RAPID_SOL_25_119_FINAL Overview The Advanced Research Projects Agency for Health (ARPA-H) recently announced the newly approved program for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID). The RAPID program aims to significantly improve outcomes for people...
Court Blocks NIH Cap on Indirect Cost Rates for Government Contracts In a significant development for research institutions and federal contractors, a federal judge has temporarily blocked the National Institutes of Health (NIH) from enforcing...
Lithium Ion Battery Development Overview of the Solicitation The Department of Energy (DOE) and affiliates have released a Request for Proposals (RFP) for the development of a safe lithium-ion battery. This initiative aims to create...
Overview The National Institutes of Health (NIH) has issued Supplemental Guidance to the 2024 NIH Grants Policy Statement regarding Indirect Cost Rates (NOT-OD-25-068). This update introduces a standardized 15% indirect cost rate for all applicable...
On January 27 and January 28, the Office of Management and Budget (OMB) issued guidance as follows: Memorandum M-25-13, an executive directive halting all federal financial assistance programs as agencies reevaluate spending priorities. An Excel...